Benitec Biopharma Inc. Share Price

Benitec Biopharma Inc. Share Price

NASDAQ: BNTC | Micro Cap
$8.13
-$0.42 (-4.91%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Benitec Biopharma Inc. Stock Performance

Open
$8.40
Prev. Close
$8.55
Circuit Range
N/A
Day Range
$8.00 - $8.40
Year Range
$8.00 - $14.39
Volume
5,419
Average Traded
$8.22

Benitec Biopharma Inc. Share Price Today

As of 18 November 2026, Benitec Biopharma Inc.'s share price is $8.13. The stock opened at $8.40, compared to its previous close of $8.55. During today's trading session, Benitec Biopharma Inc.'s share price traded between $8.00 and $8.40, with an average price of $8.20. Over the past 52 weeks, the stock has recorded a high of $14.39 and a low of $8.00. In terms of performance, Benitec Biopharma Inc.'s share price has declined by 29.55% over the last six months and is down 37.07% on a year-on-year basis.

Benitec Biopharma Inc. Share Price Chart

Line chart of the Benitec Biopharma Inc. price trend over the selected period. The price fell overall, ranging from 8.00 to 8.40, ending at 8.14.
$8.00$8.40
L
Show Current Price
H

Benitec Biopharma Inc. Stock Fundamentals & Key Indicators

Market Cap
$294.38M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.31
Revenue (TTM)
$0.00
Return On Equity (TTM)
-25.73%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-42.81%

Benitec Biopharma Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$8.97-$11.84-$11.94-$12.81
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-32.00%-0.84%-7.29%

Benitec Biopharma Inc. Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.08$0.00$0.00$0.00
Net Profit-$19.56-$22.37-$37.92-$45.55
Net Profit Margin-24450.00%N/AN/AN/A
Income ChangeN/A-14.37%-69.51%-20.12%

About Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Benitec Biopharma Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$8.49
$8.13
-7.24%
Oct 2026
$9.60
$8.77
-11.69%
Sep 2026
$12.27
$9.93
-21.60%
Aug 2026
$11.91
$12.66
+7.02%
Jul 2026
$13.22
$11.83
-11.32%
Jun 2026
$11.57
$13.34
+15.60%
May 2026
$11.84
$11.54
-4.15%
Apr 2026
$10.93
$12.04
+13.05%
Mar 2026
$10.68
$10.65
-2.47%
Feb 2026
$12.11
$10.92
-10.38%
Jan 2026
$13.48
$12.19
-9.64%
Dec 2025
$12.54
$13.48
+4.37%

BNTC Share Price FAQs